ANTIGENICS INC.

Company

AGENUS INC

Filed

April 28, 2003

Period of Report

June 10, 2003

Accession Number

0000950135-03-002623

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →